Company / R&D Expense
FENNEC PHARMACEUTICALS INC. R&D Expense History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$307.0K
FY2025
5-year range
$56.0K / $5.1M
FY2021-FY2025
Trend
+448.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense changed +448% YoY in FY2025, a notable deviation from the 9-year average annual change of +90%.
Based on SEC 10-K filings.
$307,000 in FY2025 with a 10-year CAGR of -1.5%.
Declined from $4M to $307,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -1.5%
Key checks
Key Insights
- In FY2025, r&d expense increased 448.2% year-over-year.
- Peak r&d expense was recorded in FY2021.
- Lowest r&d expense in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $307.0K | +448.2% |
| FY2024 | $56.0K | -98.4% |
| FY2023 | $3.5M | -30.8% |
| FY2021 | $5.1M | +1.9% |
| FY2019 | $5.0M | +158.7% |
| FY2018 | $1.9M | +310.2% |
| FY2017 | $472.0K | +84.4% |
| FY2016 | $256.0K | -28.3% |
| FY2015 | $357.0K | -40.2% |
| FY2014 | $597.0K | -71.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026